ArticleJournal of translational medicine2024

Progression patterns, resistant mechanisms and subsequent therapy for ALK-positive NSCLC in the era of second-generation ALK-TKIs.

Lige Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.